Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic and Therapeutic Strategies for Patients with Malignant Epidural Spinal Cord Compression

  • Neuro-oncology (GJ Lesser, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Malignant epidural spinal cord compression (MESCC) is an oncologic emergency with the potential for devastating consequences for patients if not promptly diagnosed and treated. MESCC is diagnosed by imaging. MRI is by far the most sensitive test, preferably with gadolinium. Once the diagnosis of MESCC is suspected, patients with neurologic deficits should receive prompt administration of dexamethasone with a 10-mg IV loading dose followed by 4 mg every 6 h. Quick taper is recommended once the definitive treatment is established. Consultation with medical oncology, radiation oncology, and neurosurgery is imperative in order to facilitate a multidisciplinary approach. Although spine surgery is the most effective method for relief of cord compression and is necessary if there is spinal instability, surgery is only used in selected patients because most patients have a poor overall condition and short life expectancy. Radiation therapy, therefore, is the most commonly used therapy for patients with MESCC after surgical decompression or in patients who are not surgical candidates. Conventional fractionated radiation alone can achieve modest neurologic outcomes in selected radiosensitive tumors. Radiosurgery techniques which deliver intense focal irradiation to a delimited area with imaging guidance and contoured radiation delivery to the shape of the tumor have recently emerged as increasing effective treatments in MESCC, especially in radioresistant tumors. Stereotactic radiosurgery and different radiation technologies have been studied in recent clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Kwok Y, Regine WF, Patchell RA. Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. J Clin Oncol. 2005;23(15):3308–10.

    Article  PubMed  Google Scholar 

  2. Ribas ES, Schiff D. Spinal cord compression. Curr Treat Options Neurol. 2012;14(4):391–401.

    Article  PubMed  Google Scholar 

  3. Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet. 2008;7(5):459–66.

    Article  PubMed  Google Scholar 

  4. •• Ropper AE, Ropper AH. Acute spinal cord compression. N Engl J Med. 2017;376:1358–69. A recent review on acute spinal cord compression from common causes including neoplastic epidural spinal cord compression and discussions on clinical features, assessment, and treatment options

    Article  PubMed  Google Scholar 

  5. •• Kumar A, Weber MH, Gokaslan Z, et al. Metastatic spinal cord compression and steroid treatment: a systematic review. Clin Spine Surg. 2017;30(4):156–63. A comprehensive literature review on the use of steroids and optimal steroid-dosing regimen in MESCC

    PubMed  Google Scholar 

  6. Sorensen PS, Helweg-Larsen S, Mouridsen H. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomized trial. Eur J Cancer. 1994;30(1):22–7.

    Article  Google Scholar 

  7. Delattre JY, Arbit E, Rosenblum MK, et al. High dose versus low dose dexamethasone in experimental epidural spinal compression. Neurosurgery. 1988;22:1005–7.

    Article  CAS  PubMed  Google Scholar 

  8. Delattre JY, Arbit E, Thaler HT, et al. A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J Neurosurg. 1989;70(6):920–5.

    Article  CAS  PubMed  Google Scholar 

  9. Vecht CJ, Haaxma-Reiche H, van Putten WLJ, et al. Initial bolus of conventional versus high dose dexamethasone in metastatic spinal cord compression. Neurology. 1989;39(9):1255–7.

    Article  CAS  PubMed  Google Scholar 

  10. Heimdal K, Hirschberg H, Slettebo H. High incidence of serious side effects of high dose dexamethasone treatment in patients with epidural spinal cord compression. J Neuro-Oncol. 1992;12(2):141–4.

    Article  CAS  Google Scholar 

  11. Fadul CE, Lemann W, Thaler HT, et al. Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology. 1998;38(3):348–52.

    Article  Google Scholar 

  12. Martenson JA, Evans RG, Lie MR, et al. Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC). J Neuro-Oncol. 1985;3(1):77–84.

    Article  Google Scholar 

  13. Weissman DE, Dufer D, Vogel V, et al. Corticosteroid toxicity in neuro-oncology patients. J Neuro-Oncol. 1987;5(2):125–8.

    Article  CAS  Google Scholar 

  14. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol. 2005;6(1):15–24.

    Article  PubMed  Google Scholar 

  15. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomized trial. Lancet. 2005;366(9486):643–8.

    Article  Google Scholar 

  16. Laufer L, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–51.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011;29(22):3072–7.

    Article  PubMed  Google Scholar 

  18. L’Esperance S, Vincent F, Gaudreault M, et al. Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations. Curr Oncol. 2012;19(6):478–90.

    Google Scholar 

  19. •• Watanabe N, Sugimoto Y, Tanaka M, et al. Neurological recovery after posterior spinal surgery in patients with metastatic epidural spinal cord compression. Acta Med Okaya. 2016;70(6):449–53. A recent single institutional retrospective study on deciding the proper time to perform the spinal surgery and analyzing the prognostic factors for post-operative walking ability

    Google Scholar 

  20. Klimo P, Thompson CJ, Kestle JR, et al. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-Oncology. 2005;7(1):64–76.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sundaresan N, Sachdev VP, Holland JF, et al. Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol. 1995;13(9):2330–05.

    Article  CAS  PubMed  Google Scholar 

  22. Maranzano E, Bellavita R, Rossi R, et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multi-center trial. J Clin Oncol. 2005;23(15):3358–65.

    Article  PubMed  Google Scholar 

  23. Rades D, Stalpers LJ, Veninga T, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol. 2005;23(15):3366–75.

    Article  PubMed  Google Scholar 

  24. Sze WM, Shelley M, Held I, Mason M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of the randomized trials. Cochrane Database Syst Rev. 2003;15(6):345–52.

    CAS  Google Scholar 

  25. • Anand AK, Venkadamanickam G, Punnakal AU, et al. Hypofractionated stereotactic body radiotherapy in spinal metastasis—with or without epidural extension. Clin Oncol. 2015;27(6):345–52. SBRT resulted in high rates or pain control and local extension of MESCC

    Article  CAS  Google Scholar 

  26. Hashmi A, Guckenberger M, Kersh R. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. 2016;25(5):646–53.

    Article  PubMed  Google Scholar 

  27. Chow E, van der Linden YM, Roos D, et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomized, controlled, non-inferiority trial. Lancet Oncol. 2014;15(2):164–71.

    Article  PubMed  Google Scholar 

  28. Maralani J, Lo SS, Redmond K. Spinal metastases: multimodality imaging in diagnosis and stereotactic body radiation therapy planning. Future Oncol. 2017;13(1):77–91.

    Article  Google Scholar 

  29. Garg AK, Wang XS, Shiu AS, et al. Prospective evaluation of spinal irradiation by using stereotactic body radiation therapy: the University of Texas MD Anderson Cancer Center experience. Cancer. 2011;117(15):3509–16.

    Article  PubMed  Google Scholar 

  30. Damast S, Wright J, Bilsky M. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. Int J Radiat Oncol Biol Phy. 2011;81(3):819–26.

    Article  Google Scholar 

  31. Chang UK, Cho WI, Kim MS, Cho CK, Lee DH, Rhee CH. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol. 2012;51(5):589–95.

    Article  PubMed  Google Scholar 

  32. • Bate BG, Khan NR, Kimball BY, et al. Stereotactic radiosurgery for spinal metastases with or without separation surgery. J Neurosurg Spine. 2015;22(4):409–15. Discussions on novel surgical techniques in MESCC

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Oncology, Washington University in St Louis School of Medicine, 660 South Euclid Avenue, Campus Box 8056, St Louis, MO, 63110, USA

    Dilan A. Patel MD & Jian L. Campian MD, PhD

Authors
  1. Dilan A. Patel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian L. Campian MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian L. Campian MD, PhD.

Ethics declarations

Conflict of Interest

Dilan A. Patel and Jian L. Campian declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Neuro-oncology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, D.A., Campian, J.L. Diagnostic and Therapeutic Strategies for Patients with Malignant Epidural Spinal Cord Compression. Curr. Treat. Options in Oncol. 18, 53 (2017). https://doi.org/10.1007/s11864-017-0497-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-017-0497-6

Keywords

Search

Navigation